STOCK TITAN

SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has scheduled its first quarter 2025 financial results announcement for May 5, 2025, after market close. The company will hold a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results.

Investors can participate in the conference call by registering through the provided link. The webcast will be accessible through the company's website's 'Investors' section and will remain available for replay for at least 90 days following the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-2.32% News Effect

On the day this news was published, SIBN declined 2.32%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 4,300 physicians in performing a total of over 115,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 160 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, sacropelvic fixation and pelvic trauma.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

iFuse Bedrock Granite, iFuse TORQ, iFuse TORQ TNT, SI-BONE, and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal investors@si-bone.com


FAQ

When will SI-BONE (SIBN) release Q1 2025 earnings?

SI-BONE will release Q1 2025 earnings on May 5, 2025, after market close.

What time is SI-BONE's (SIBN) Q1 2025 earnings call?

The earnings call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on May 5, 2025.

How can investors access SI-BONE's (SIBN) Q1 2025 earnings call?

Investors can register for the call through a provided link or access the webcast through the 'Investors' section of SI-BONE's website.

How long will SI-BONE's (SIBN) Q1 2025 earnings webcast be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.
Si-Bone

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Latest SEC Filings

SIBN Stock Data

798.83M
39.43M
2.98%
96.62%
5.01%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA